Cytodyn Stock Price Prediction
| CYDY Stock | USD 0.11 0.01 8.33% |
Oversold Vs Overbought
39
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cytodyn based on different types of headlines from major news networks to social media. Using Cytodyn hype-based prediction, you can estimate the value of Cytodyn from the perspective of Cytodyn response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Cytodyn. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cytodyn to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Cytodyn because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cytodyn after-hype prediction price | USD 0.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cytodyn |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytodyn's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytodyn After-Hype Price Prediction Density Analysis
As far as predicting the price of Cytodyn at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytodyn or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Cytodyn, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cytodyn Estimiated After-Hype Price Volatility
In the context of predicting Cytodyn's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytodyn's historical news coverage. Cytodyn's after-hype downside and upside margins for the prediction period are 0.01 and 4.50, respectively. We have considered Cytodyn's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cytodyn is out of control at this time. Analysis and calculation of next after-hype price of Cytodyn is based on 3 months time horizon.
Cytodyn OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Cytodyn is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytodyn backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytodyn, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 4.39 | 0.00 | 0.76 | 0 Events / Month | 6 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.11 | 0.11 | 0.00 |
|
Cytodyn Hype Timeline
Cytodyn is currently traded for 0.11. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.76. Cytodyn is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.49%. %. The volatility of related hype on Cytodyn is about 283.41%, with the expected price after the next announcement by competition of 0.87. The company recorded a loss per share of 0.23. Cytodyn had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Cytodyn Basic Forecasting Models to cross-verify your projections.Cytodyn Related Hype Analysis
Having access to credible news sources related to Cytodyn's direct competition is more important than ever and may enhance your ability to predict Cytodyn's future price movements. Getting to know how Cytodyn's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytodyn may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ICPT | Intercept Pharmaceuticals | 0.66 | 3 per month | 0.00 | (0.18) | 5.23 | (8.32) | 38.17 | |
| MDGL | Madrigal Pharmaceuticals | 15.47 | 8 per month | 2.12 | 0.08 | 5.17 | (3.96) | 30.27 | |
| SCPH | Scpharmaceuticals | (0.03) | 8 per month | 0.00 | (0.15) | 4.30 | (7.09) | 20.70 | |
| AKRO | Akero Therapeutics | (0.28) | 9 per month | 2.62 | 0.06 | 5.23 | (4.45) | 13.37 | |
| ARAV | Aravive | (0.17) | 1 per month | 0.00 | (0.07) | 7.14 | (7.83) | 26.51 | |
| CRDF | Cardiff Oncology | (0.20) | 4 per month | 5.99 | 0.04 | 9.48 | (8.03) | 41.21 | |
| RVPH | Reviva Pharmaceuticals Holdings | (0.04) | 5 per month | 5.90 | 0.06 | 10.71 | (9.86) | 40.06 | |
| EFTR | Effector Therapeutics | (0.06) | 4 per month | 0.00 | (0.31) | 8.70 | (27.78) | 88.91 | |
| PDSB | PDS Biotechnology Corp | 0.14 | 10 per month | 0.00 | (0.11) | 7.67 | (6.76) | 31.83 | |
| NAVB | Navidea Biopharmaceuticals | 0.00 | 0 per month | 0.00 | (0.15) | 12.50 | (12.50) | 40.40 |
Cytodyn Additional Predictive Modules
Most predictive techniques to examine Cytodyn price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytodyn using various technical indicators. When you analyze Cytodyn charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cytodyn Predictive Indicators
The successful prediction of Cytodyn stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytodyn, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytodyn based on analysis of Cytodyn hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytodyn's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytodyn's related companies.
Story Coverage note for Cytodyn
The number of cover stories for Cytodyn depends on current market conditions and Cytodyn's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytodyn is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytodyn's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cytodyn Short Properties
Cytodyn's future price predictability will typically decrease when Cytodyn's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytodyn often depends not only on the future outlook of the potential Cytodyn's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytodyn's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 719.6 M | |
| Cash And Short Term Investments | 4.2 M |
Additional Tools for Cytodyn OTC Stock Analysis
When running Cytodyn's price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.